Management of Elevated BUN with Normal Kidney Function

Initial Assessment

The European Society of Cardiology recommends evaluating volume status by checking for clinical signs of dehydration and assessing for heart failure, as patients with elevated BUN and normal kidney function may have a pre-renal state or increased protein catabolism 1, 2
Normal kidney function should be confirmed with serum creatinine, according to the American College of Physicians 1

The European Journal of Heart Failure suggests administering intravenous fluids if signs of dehydration are present, and monitoring response with serial BUN measurements 2, 1
The American Heart Association recommends optimizing heart failure management according to guidelines, considering diuretics if fluid overloaded, and evaluating protein intake 2
The National Comprehensive Cancer Network recommends identifying and treating any underlying infections or sepsis, and following appropriate antibiotic guidelines if infection is present 3

The American College of Physicians recommends following BUN levels serially until normalization, monitoring fluid status, and reassessing kidney function regularly with serum creatinine 1, 2

The American Geriatrics Society notes that elderly patients often have lower muscle mass, resulting in lower creatinine production despite reduced kidney function, and recommends considering this when evaluating kidney function 1

The American Heart Association, as published in Circulation, recommends optimizing heart failure management, including the use of loop diuretics and potentially combined with metolazone for diuretic resistance, in patients with elevated BUN and normal creatinine 4
The American Heart Association, as published in Circulation, suggests that small to moderate BUN/creatinine elevations during diuresis should not prompt therapy reduction unless severe renal dysfunction develops, and recommends restricting dietary sodium to ≤2g daily 4
The American Heart Association, as published in Circulation, advises continuing ACE inhibitors and beta-blockers despite elevated BUN, as neurohormonal antagonism benefits persist in advanced disease 4
The National Kidney Foundation, as published in the American Journal of Kidney Diseases, recommends not relying on BUN or creatinine alone to monitor renal function progression, especially in diabetics, elderly, malnourished, or those with low muscle mass 5